Brighton and Sussex University Hospitals manage a significant prostate cancer patient population across the South East. For Brighton patients requiring private access to Abiraterone — whether due to NHS eligibility criteria, waiting times, or preference — generic Abiranamo provides identical clinical benefit at a fraction of branded cost.
Prostate cancer is Brighton's most commonly diagnosed male cancer. Abiranamo's mechanism of blocking CYP17A1 androgen synthesis continues to deliver meaningful survival benefit for mCRPC patients, with newer formulations also available at 500mg doses (4 x 125mg) for those preferring the food-flexible dosing schedule.
Visit medshopy.com or WhatsApp +91 82650 41513.
Prostate cancer is Brighton's most commonly diagnosed male cancer. Abiranamo's mechanism of blocking CYP17A1 androgen synthesis continues to deliver meaningful survival benefit for mCRPC patients, with newer formulations also available at 500mg doses (4 x 125mg) for those preferring the food-flexible dosing schedule.
Visit medshopy.com or WhatsApp +91 82650 41513.
Is there a newer formulation of Abiraterone that can be taken with food?Yes — a newer micronised formulation of Abiraterone (Yonsa/Zurzuvae in the US, available in some markets) can be taken with a low-fat meal at a lower dose, addressing the strict empty-stomach requirement of the original 250mg tablet. However, the standard 250mg Abiraterone Acetate tablet (as in Abiranamo) remains the most widely used and well-studied formulation globally. If the food restriction is causing practical difficulties, discuss with your oncologist whether an alternative formulation might be accessible for your specific situation in the UK.